At a glance
ClinicalIndex Comparison RecordN/ACompleted· 221 enrolled
Drug / intervention
Transvaginal sonographydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Controlled Ultrasound Based Study For Niche Development In The Uterine Cesarean Section Scar With Hysteroscopic Correlation In Symptomatizing Patients
In Brief
An observational study evaluating Transvaginal sonography for Cesarean Section; Dehiscence. Completed, enrolled 221 participants across 1 site.
Detailed Summary
The aim of this study is to evaluate different factors affecting niche development in the uterine cesarean section scar in women enrolled 3 to 6 months after cesarean delivery using both TVS and SIS.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCesarean Section; Dehiscence
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedMar 2019
Primary CompletionJun 2019
Study CompletionJul 2019
TodayJul 2026
First PostedMar 1, 2019
Enrollment StartJul 1, 2017
Primary CompletionJun 30, 2019
Study CompletionJul 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 7.3 years ago
Interventions
Transvaginal sonographydevice
Niche is assessed using TVS, SIS (cases only) and office hysteroscopy